Brian G. Katona

2.6k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Brian G. Katona is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian G. Katona has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian G. Katona's work include Peripheral Artery Disease Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Brian G. Katona is often cited by papers focused on Peripheral Artery Disease Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Brian G. Katona collaborates with scholars based in United States, United Kingdom and Sweden. Brian G. Katona's co-authors include W. Schuyler Jones, Jeffrey S. Berger, Manesh R. Patel, Lars Norgren, Juuso Blomster, Iris Baumgärtner, Kenneth W. Mahaffey, William R. Hiatt, Peter Held and F. Gerry R. Fowkes and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Brian G. Katona

25 papers receiving 1.1k citations

Hit Papers

Ticagrelor versus Clopidogrel in Symptomatic Peripheral A... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
    2016 386 citations William R. Hiatt, F. Gerry R. Fowkes et al. New England Journal of Medicine profile →

Peers

Brian G. Katona
Gursharan Dogra Australia
S. Braun Germany
Mir Abolfazl Ostad Germany
Yongwhi Park South Korea
Roberta Giacomello Italy
Yung‐Chang Chen Taiwan
Ryan J. Lennon United States
Vikram Agarwal United States
Moshe Vardi Israel
Bartosz Hudzik Poland
Gursharan Dogra Australia
Brian G. Katona
Citations per year, relative to Brian G. Katona Brian G. Katona (= 1×) peers Gursharan Dogra

Countries citing papers authored by Brian G. Katona

Since Specialization
Citations

This map shows the geographic impact of Brian G. Katona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian G. Katona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian G. Katona more than expected).

Fields of papers citing papers by Brian G. Katona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian G. Katona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian G. Katona. The network helps show where Brian G. Katona may publish in the future.

Co-authorship network of co-authors of Brian G. Katona

This figure shows the co-authorship network connecting the top 25 collaborators of Brian G. Katona. A scholar is included among the top collaborators of Brian G. Katona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian G. Katona. Brian G. Katona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Vishal N., Abhinav Sharma, Amanda Stebbins, et al.. (2024). Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL. American Heart Journal. 271. 123–135.
2.
3.
Szarek, Michael, Connie N. Hess, Manesh R. Patel, et al.. (2022). TOTAL CARDIOVASCULAR AND LIMB EVENTS WITH TICAGRELOR AND CLOPIDOGREL IN PATIENTS WITH SYMPTOMATIC PAD IN THE EUCLID TRIAL. Journal of the American College of Cardiology. 79(9). 1744–1744. 1 indexed citations
4.
Weissler, E. Hope, Robert M. Clare, Yuliya Lokhnygina, et al.. (2021). Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial. Diabetic Medicine. 38(10). e14552–e14552. 6 indexed citations
5.
Kavanagh, Sarah, Jeffrey S. Berger, Connie N. Hess, et al.. (2020). Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease. Journal of the American College of Cardiology. 75(6). 608–617. 27 indexed citations
6.
7.
Bethel, M. Angelyn, Robert J. Mentz, Peter Merrill, et al.. (2019). Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. Diabetes Care. 43(2). 446–452. 78 indexed citations
8.
Hess, Connie N., Zhen Huang, Manesh R. Patel, et al.. (2019). Acute Limb Ischemia in Peripheral Artery Disease. Circulation. 140(7). 556–565. 73 indexed citations
9.
Bethel, M. Angelyn, Robert J. Mentz, Peter Merrill, et al.. (2018). Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes. 67(Supplement_1). 46 indexed citations
10.
Berger, Jeffrey S., Beth L. Abramson, Renato D. Lópes, et al.. (2018). Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. Vascular Medicine. 23(6). 523–530. 29 indexed citations
11.
Norgren, Lars, Manesh R. Patel, William R. Hiatt, et al.. (2017). Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. European Journal of Vascular and Endovascular Surgery. 55(1). 109–117. 22 indexed citations
12.
Hiatt, William R., F. Gerry R. Fowkes, Gretchen Heizer, et al.. (2016). Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. New England Journal of Medicine. 376(1). 32–40. 386 indexed citations breakdown →
13.
Berger, Jeffrey S., Brian G. Katona, W. Schuyler Jones, et al.. (2016). Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. American Heart Journal. 175. 86–93. 38 indexed citations
14.
Berger, Jeffrey S., Brian G. Katona, Juan Maya, et al.. (2012). Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature. American Heart Journal. 164(2). 153–162.e5. 22 indexed citations
15.
Zimmermann, Anthony E., et al.. (1993). Ceftriaxone-Induced Acute Pancreatitis. Annals of Pharmacotherapy. 27(1). 36–37. 24 indexed citations
16.
Goss, Thomas F., et al.. (1992). Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients.. PubMed. 12(4). 283–91. 6 indexed citations
17.
Goss, Thomas F., et al.. (1992). Prospective Evaluation of Risk Factors for Antibiotic‐Associated Bleeding in Critically III Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(4). 283–291. 5 indexed citations
18.
Katona, Brian G., et al.. (1989). The Effect of “Superactive” charcoal and magnesium citrate solution on blood ethanol concentrations and area under the curve in humans.. Journal of Toxicology Clinical Toxicology. 27(1-2). 129–137. 6 indexed citations
19.
Katona, Brian G. & Suman Wason. (1989). Superwarfarin poisoning. Journal of Emergency Medicine. 7(6). 627–631. 17 indexed citations
20.
Katona, Brian G., et al.. (1989). Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit. American Journal of Health-System Pharmacy. 46(6). 1179–1182. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gursharan Dogra Breakdown of academic impact, for papers by S. Braun Breakdown of academic impact, for papers by Mir Abolfazl Ostad Breakdown of academic impact, for papers by Yongwhi Park Breakdown of academic impact, for papers by Roberta Giacomello Breakdown of academic impact, for papers by Yung‐Chang Chen Breakdown of academic impact, for papers by Ryan J. Lennon Breakdown of academic impact, for papers by Vikram Agarwal Breakdown of academic impact, for papers by Moshe Vardi Breakdown of academic impact, for papers by Bartosz Hudzik
Rankless by CCL
2026